130 related articles for article (PubMed ID: 6602120)
1. Synthesis and beta-lactamase inhibitory activities of some clavulanic acid analogues.
Mak CP; Prasad K; Turnowsky F
J Antibiot (Tokyo); 1983 Apr; 36(4):398-406. PubMed ID: 6602120
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
3. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
Cullmann W; Binder S; Stieglitz M
Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
[TBL] [Abstract][Full Text] [Related]
4. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
Grace ME; Fu KP; Gregory FJ; Hung PP
Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
[TBL] [Abstract][Full Text] [Related]
5. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam.
Chin NX; McElrath MJ; Neu HC
Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139
[TBL] [Abstract][Full Text] [Related]
6. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.
Reading C; Cole M
Antimicrob Agents Chemother; 1977 May; 11(5):852-7. PubMed ID: 879738
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.
Coleman K; Griffin DR; Page JW; Upshon PA
Antimicrob Agents Chemother; 1989 Sep; 33(9):1580-7. PubMed ID: 2817854
[TBL] [Abstract][Full Text] [Related]
9. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. II. Antibacterial properties.
Angehrn P; Arisawa M
J Antibiot (Tokyo); 1982 Nov; 35(11):1584-9. PubMed ID: 6298168
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
Qadri SM; Ueno Y; Cunha BA
Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
[TBL] [Abstract][Full Text] [Related]
11. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
Muratani T; Yokota E; Nakane T; Inoue E; Mitsuhashi S
J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
[TBL] [Abstract][Full Text] [Related]
12. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
Matsuura M; Nakazawa H; Hashimoto T; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Jun; 17(6):908-11. PubMed ID: 6967713
[TBL] [Abstract][Full Text] [Related]
13. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
Aldridge KE; Sanders CV; Marier RL
J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724
[TBL] [Abstract][Full Text] [Related]
14. Biochemistry and action of clavulanic acid.
Cole M
Scott Med J; 1982; 27 Spec No.():S10-6. PubMed ID: 6762660
[TBL] [Abstract][Full Text] [Related]
15. Beta-lactamase inhibitory activities and synergistic effects of 5,6-cis-carbapenem antibiotics.
Okonogi K; Harada S; Shinagawa S; Imada A; Kuno M
J Antibiot (Tokyo); 1982 Aug; 35(8):963-71. PubMed ID: 6982889
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
Neu HC
Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland.
Thomson CJ; Amyes SG
Epidemiol Infect; 1993 Feb; 110(1):117-25. PubMed ID: 8432315
[TBL] [Abstract][Full Text] [Related]
18. In-vitro susceptibility of Nocardia asteroides to 21 beta-lactam antibiotics, in combination with three beta-lactamase inhibitors, and its relationship to the beta-lactamase content.
Kitzis MD; Gutmann L; Acar JF
J Antimicrob Chemother; 1985 Jan; 15(1):23-30. PubMed ID: 3882654
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of cefodizime (HR-221) in combination with beta-lactamase inhibitors.
Segatore B; Perilli M; Franceschini N; Setacci D; Oratore A; Amicosante G
J Chemother; 1993 Jun; 5(3):147-50. PubMed ID: 8396624
[TBL] [Abstract][Full Text] [Related]
20. Resistance of Aeromonas hydrophila to beta-lactam antibiotics.
Zemelman R; Gonzalez C; Mondaca MA; Silva J; Merino C; Dominguez M
J Antimicrob Chemother; 1984 Dec; 14(6):575-9. PubMed ID: 6335147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
